GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (STU:1NP1) » Definitions » YoY Rev. per Sh. Growth

Flerie AB (STU:1NP1) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Flerie AB YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Flerie AB's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 0.00%.

Flerie AB's Revenue per Share for the three months ended in Mar. 2025 was €0.00.

Flerie AB YoY Rev. per Sh. Growth Historical Data

The historical data trend for Flerie AB's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flerie AB YoY Rev. per Sh. Growth Chart

Flerie AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.00 -100.00 - - -

Flerie AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -100.00 - - -

Flerie AB YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Flerie AB's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2024 )
=(Revenue per Share (A: Dec. 2024 )-Revenue per Share (A: Dec. 2023 ))/ | Revenue per Share (A: Dec. 2023 ) |
=(0-0)/ | 0 |
=N/A %

Flerie AB's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Flerie AB YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Flerie AB's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Flerie AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (STU:1NP1) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
OSTO:BINV OSTO:VICO OSTO:GENO OSTO:HNSA OSTO:DMYD B OSTO:SANION OSTO:XSPRAY OSTO:EGTX OSTO:SYNACT OSTO:IBT B VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
FLERIE:Sweden
Address
Skeppsbron 16, Stockholm, SWE, 111 30
Website
https://www.flerie.com/en
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Flerie AB Headlines

No Headlines